p53 Gene (NY-CO-13) Levels in Patients with Chronic Myeloid Leukemia: The Role of Imatinib and Nilotinib.

Diseases · 2018 · PMC5871959 · PMID 29370077

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The differences in the hematological profile revealed highly significant differences in white blood cells, platelet count, plateletcrit percentage and mean corpuscular hemoglobin concentration in patients with CML compared with control ( p < 0.01).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.